Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
RECOVER released a call for ancillary pathobiology study proposals that will build on the more than 60 existing funded studies and will address unanswered questions about Long COVID.
Leveraging staff expertise and consistent monitoring, a RECOVER-ENERGIZE clinical trial is exploring whether a personalized cardiopulmonary rehabilitation program can help people with Long COVID regain physical activity.
Researchers found that severe COVID-19 can cause a strong immune response, which can cause the body’s immune system to attack itself and lead to new autoimmune diseases.
Drawing on her experience working in intensive care, expertise in lung health, and knowledge of medical imaging, Dr. Brosnahan is leading studies that could inform the development of treatments for specific Long COVID symptoms.
A study published in Annals of Internal Medicine—led by RECOVER researchers at Mass General Brigham—shows financial hardship, food insecurity, lack of healthcare access, and other social risk factors increase the risk for Long COVID.
At a recent RECOVER Research Review (R3) Seminar held July 8, RECOVER researchers Rachel Gross, MD, MS; and Tanayott (Tony) Thaweethai, PhD, presented key findings from their study recently published in Journal of the American Medical Association (JAMA) Pediatrics. They were joined by RECOVER Representatives Krista Coombs and Megan Carmilani, who shared personal stories and reflections about the study findings. Amy Salisbury, PhD, RN, FAAN, a coauthor of the publication, facilitated the discussion.
This year, RECOVER researchers continue to publish results from research studies that deepen our understanding of Long COVID. RECOVER studies continue, with 2 clinical trials expected to reach enrollment goals this summer.
A team of community engagement experts from NIH’s Community Engagement Alliance Consultative Resource (CEACR) is helping RECOVER meet the needs of communities most impacted by Long COVID.
During a recent RECOVER Research Review (R3) seminar, RECOVER researchers Torri Metz, MD, MS, Chengxi Zang, PhD, and Valerie Flaherman, MD, MPH, shared findings from two major studies examining the risk of developing Long COVID following a SARS-CoV-2 infection during pregnancy. Drawing on data from RECOVER’s observational study of pregnant women and from two national electronic health record (EHR) research networks, these studies represent some of the largest efforts to date exploring the relationship between pregnancy and Long COVID.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.
